{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=SAR231893", "query": { "intervention": "SAR231893" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 69, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=SAR231893&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-23T18:51:49.052Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03558997", "title": "Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Allergic Rhinitis" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Timothy Grass SCIT", "type": "DRUG" }, { "name": "Placebo matching dupilumab", "type": "DRUG" }, { "name": "Placebo matching SCIT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 103, "start_date": "2018-06-07", "completion_date": "2019-06-13", "has_results": true, "last_update_posted_date": "2020-05-28", "last_synced_at": "2026-09-23T18:51:49.052Z", "location_count": 12, "location_summary": "Los Angeles, California • Mountain View, California • Walnut Creek, California + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Mountain View", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03558997" }, { "nct_id": "NCT02528214", "title": "Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Oral corticosteroid therapy (prednisone/prednisolone)", "type": "DRUG" }, { "name": "Inhaled corticosteroid (ICS) therapy", "type": "DRUG" }, { "name": "Albuterol/Salbutamol", "type": "DRUG" }, { "name": "Levalbuterol/Levosalbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 210, "start_date": "2015-10-15", "completion_date": "2017-11-13", "has_results": true, "last_update_posted_date": "2019-10-01", "last_synced_at": "2026-09-23T18:51:49.052Z", "location_count": 8, "location_summary": "Los Angeles, California • Rolling Hills Estates, California • St Louis, Missouri + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Amarillo", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02528214" }, { "nct_id": "NCT05976360", "title": "A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer" ], "interventions": [ { "name": "Dupilumab (SAR231893)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 38, "start_date": "2014-11-02", "completion_date": "2015-01-17", "has_results": false, "last_update_posted_date": "2023-08-04", "last_synced_at": "2026-09-23T18:51:49.052Z", "location_count": 2, "location_summary": "Saint Paul, Minnesota • Springfield, Missouri", "locations": [ { "city": "Saint Paul", "state": "Minnesota" }, { "city": "Springfield", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05976360" }, { "nct_id": "NCT02414854", "title": "Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Inhaled corticosteroid (ICS) therapy", "type": "DRUG" }, { "name": "Albuterol/Salbutamol", "type": "DRUG" }, { "name": "Levalbuterol/Levosalbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1902, "start_date": "2015-04-27", "completion_date": "2017-11-23", "has_results": true, "last_update_posted_date": "2018-10-23", "last_synced_at": "2026-09-23T18:51:49.052Z", "location_count": 116, "location_summary": "Birmingham, Alabama • Flagstaff, Arizona • Gilbert, Arizona + 100 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Flagstaff", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02414854" }, { "nct_id": "NCT07053423", "title": "A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 218, "start_date": "2025-09-22", "completion_date": "2029-02-02", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-09-23T18:51:49.052Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Miami, Florida • Cordele, Georgia + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Cordele", "state": "Georgia" }, { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07053423" }, { "nct_id": "NCT04442269", "title": "Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Allergic Bronchopulmonary Aspergillosis" ], "interventions": [ { "name": "dupilumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 62, "start_date": "2020-09-15", "completion_date": "2024-02-09", "has_results": true, "last_update_posted_date": "2025-04-04", "last_synced_at": "2026-09-23T18:51:49.052Z", "location_count": 13, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Bakersfield, California + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04442269" }, { "nct_id": "NCT03930732", "title": "Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Dupilumab SAR231893", "type": "DRUG" }, { "name": "Inhaled Corticosteroid", "type": "DRUG" }, { "name": "Inhaled Long-Acting Beta Agonist", "type": "DRUG" }, { "name": "Inhaled Long-Acting Muscarinic Antagonist", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 939, "start_date": "2019-04-15", "completion_date": "2023-05-02", "has_results": true, "last_update_posted_date": "2024-02-28", "last_synced_at": "2026-09-23T18:51:49.052Z", "location_count": 51, "location_summary": "Andalusia, Alabama • Birmingham, Alabama • Dothan, Alabama + 46 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT03930732" }, { "nct_id": "NCT04823130", "title": "Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Dermatitis Atopic" ], "interventions": [ { "name": "Dupilumab (SAR231893)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2021-04-22", "completion_date": "2022-08-30", "has_results": true, "last_update_posted_date": "2025-09-16", "last_synced_at": "2026-09-23T18:51:49.052Z", "location_count": 2, "location_summary": "Miami, Florida • East Windsor, New Jersey", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "East Windsor", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04823130" }, { "nct_id": "NCT04400318", "title": "The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 109, "start_date": "2020-06-20", "completion_date": "2023-08-21", "has_results": true, "last_update_posted_date": "2025-09-09", "last_synced_at": "2026-09-23T18:51:49.052Z", "location_count": 10, "location_summary": "Westminster, California • Kansas City, Kansas • Ann Arbor, Michigan + 6 more", "locations": [ { "city": "Westminster", "state": "California" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Chesterfield", "state": "Missouri" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04400318" }, { "nct_id": "NCT02379052", "title": "Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Eosinophilic Esophagitis" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 47, "start_date": "2015-05-12", "completion_date": "2017-07-10", "has_results": true, "last_update_posted_date": "2020-02-28", "last_synced_at": "2026-09-23T18:51:49.052Z", "location_count": 14, "location_summary": "Idaho Falls, Idaho • Chicago, Illinois • Urbana, Illinois + 11 more", "locations": [ { "city": "Idaho Falls", "state": "Idaho" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Urbana", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02379052" } ] }